Previously Funded Researchers
See researchers who have made a difference in research we have funded prior to 2018 through our nationwide research awards, showcasing the breadth of the work and scientists we have supported.-
Ji Yeon Kim, PhD
University of Illinois
Shedding Light on Link Between Mutations and Metabolism in Lung Cancer
-
Bora Youn, M.P.H., M.S.
Brown University
Non-Small Cell Lung Cancer Treatment in the Elderly
-
Jacob Yount, PhD
Ohio State University
Measuring Effect of Anti-Inflammatory Protein on SARS-CoV-2
-
Maryam Yousefi, Ph.D.
Stanford University
Evaluating Lung Cancer Treatment on Different Genetic Variations
-
Xiaoyi Yuan, Ph.D.
University of Texas Health Science Center at Houston
Evaluating Role of MicroRNA as Therapeutic Target for ARDS
-
Zafar Zafari, M.D., Ph.D
University of Maryland at Baltimore
Which Interventions for COPD are Most Cost-Effective?
-
Igor Zelko, Ph.D.
University of Louisville
Blocking Remodeling in Lung's Blood Vessels in Pulmonary Arterial Hypertension
-
Rachel Lynne Zemans, MD
The Regents of the University of Michigan
Mechanisms of Failed Epithelial Regeneration in the Pathogenesis of Pulmonary Fibrosis
-
William Zhengyang Zhang, MD
Weill Cornell Medical College
Developing Novel COPD Treatments That Target Iron
-
Junran Zhang, M.D., Ph.D.
The Ohio State University College of Medicine
Inhibiting Enzyme Required for Cholesterol Synthesis May Suppress Growth of NSCLC
-
Ruogang Zhao, PhD
University of Buffalo
Developing Models to Screen Drugs for Idiopathic Pulmonary Fibrosis
-
Jing Zhao, Ph.D.
University of Pittsburgh
Reducing Anti-Inflammatory Effects of Protein Involved in Acute Lung Injury
-
Jinming Zhao, Ph.D.
University of Pittsburgh
Suppressing Enzyme Involved in Asthma Activation
-
Guofei Zhou, Ph.D.
University of Illinois, Chicago
Role of Tumor Suppressor Protein in Pulmonary Fibrosis
-
Jay L. Zweier, M.D.
The Ohio State University
Electronic Cigarettes in Lung Cancer Development